{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:08:29Z","timestamp":1790712509863,"version":"4.1.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.lpm.2017.04.010","type":"journal-article","created":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:15:28Z","timestamp":1496276128000},"page":"e97-e108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":89,"special_numbering":"P2","title":["The diagnosis of cystic fibrosis"],"prefix":"10.1016","volume":"46","author":[{"given":"Kris","family":"De Boeck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francois","family":"Vermeulen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lieven","family":"Dupont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2017.04.010_bib0365","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0022-3476(98)70344-0","article-title":"The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel","volume":"132","author":"Rosenstein","year":"1998","journal-title":"J Pediatr"},{"key":"10.1016\/j.lpm.2017.04.010_bib0370","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1164\/rccm.200509-1377OC","article-title":"Mutations in the cystic fibrosis transmembrane regulator gene and in vivo transepithelial potentials","volume":"174","author":"Wilschanski","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"Suppl 2","key":"10.1016\/j.lpm.2017.04.010_bib0375","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1016\/S1569-1993(11)60009-X","article-title":"New clinical diagnostic procedures for cystic fibrosis in Europe","volume":"10","author":"De Boeck","year":"2011","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.lpm.2017.04.010_bib0380","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jcf.2013.08.006","article-title":"Nasal potential difference measurements in diagnosis of cystic fibrosis: an international survey","volume":"13","author":"Naehrlich","year":"2014","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.lpm.2017.04.010_bib0385","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1136\/thx.2005.043539","article-title":"Cystic fibrosis: terminology and diagnostic algorithms","volume":"61","author":"De Boeck","year":"2006","journal-title":"Thorax"},{"key":"10.1016\/j.lpm.2017.04.010_bib0390","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1136\/thx.2008.104752","article-title":"Phenotypic characterisation of patients with intermediate sweat chloride values: towards validation of the European diagnostic algorithm for cystic fibrosis","volume":"64","author":"Goubau","year":"2009","journal-title":"Thorax"},{"key":"10.1016\/j.lpm.2017.04.010_bib0395","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.jpeds.2008.05.005","article-title":"Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report","volume":"153","author":"Farrell","year":"2008","journal-title":"J Pediatr"},{"key":"10.1016\/j.lpm.2017.04.010_bib0400","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1136\/thoraxjnl-2011-201454","article-title":"Comparing the American and European diagnostic guidelines for cystic fibrosis: same disease, different language?","volume":"67","author":"Ooi","year":"2012","journal-title":"Thorax"},{"key":"10.1016\/j.lpm.2017.04.010_bib0405","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1136\/thoraxjnl-2013-203832","article-title":"Does extensive genotyping and nasal potential difference testing clarify the diagnosis of cystic fibrosis among patients with single-organ manifestations of cystic fibrosis?","volume":"69","author":"Ooi","year":"2014","journal-title":"Thorax"},{"key":"10.1016\/j.lpm.2017.04.010_bib0410","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jcf.2016.06.009","article-title":"Nasal potential difference outcomes support diagnostic decisions in cystic fibrosis","volume":"15","author":"Tridello","year":"2016","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.lpm.2017.04.010_bib0415","doi-asserted-by":"crossref","first-page":"e47708","DOI":"10.1371\/journal.pone.0047708","article-title":"Measurements of CFTR-mediated Cl-secretion in human rectal biopsies constitute a robust biomarker for cystic fibrosis diagnosis and prognosis","volume":"7","author":"Sousa","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.lpm.2017.04.010_bib0420","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/ppul.22586","article-title":"Evaluation of the intestinal current measurement method as a diagnostic test for cystic fibrosis","volume":"48","author":"Cohen-Cymberknoh","year":"2013","journal-title":"Pediatr Pulmonol"},{"issue":"Suppl. 2","key":"10.1016\/j.lpm.2017.04.010_bib0425","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1016\/S1569-1993(11)60014-3","article-title":"Recommendations for the classification of diseases as CFTR-related disorders","volume":"10","author":"Bombieri","year":"2011","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.lpm.2017.04.010_bib0430","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1542\/peds.2006-1498","article-title":"Cystic fibrosis diagnosed after 2 months of age leads to worse outcomes and requires more therapy","volume":"119","author":"Sims","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.lpm.2017.04.010_bib0435","first-page":"41","article-title":"Clinical status and somatic development of patients with or without meconium ileus diagnosed through neonatal screening for cystic fibrosis","volume":"19","author":"Zybert","year":"2015","journal-title":"Dev Period Med"},{"key":"10.1016\/j.lpm.2017.04.010_bib0440","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ymgme.2014.07.012","article-title":"Differences in clinical condition and genotype at time of diagnosis of cystic fibrosis by newborn screening or by symptoms","volume":"113","author":"Vernooij-van Langen","year":"2014","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.lpm.2017.04.010_bib0445","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jcf.2009.01.004","article-title":"European best practice guidelines for cystic fibrosis neonatal screening","volume":"8","author":"Castellani","year":"2009","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.lpm.2017.04.010_bib0450","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jpeds.2007.03.002","article-title":"Diagnostic sweat testing: the Cystic Fibrosis Foundation guidelines","volume":"151","author":"LeGrys","year":"2007","journal-title":"J Pediatr"},{"key":"10.1016\/j.lpm.2017.04.010_bib0455","series-title":"Sweat testing: sample collection and quantitative analysis Approved guideline C34A2","author":"National Committee for Clinical Laboratory Standards (NCCLS)","year":"2000"},{"key":"10.1016\/j.lpm.2017.04.010_bib0460","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.jped.2015.03.003","article-title":"Sweat conductivity and coulometric quantitative test in neonatal cystic fibrosis screening","volume":"91","author":"Domingos","year":"2015","journal-title":"J Pediatr (Rio J)"},{"key":"10.1016\/j.lpm.2017.04.010_bib0465","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s00431-015-2501-0","article-title":"Clinical evaluation of the Nanoduct sweat test system in the diagnosis of cystic fibrosis after newborn screening","volume":"174","author":"Vernooij-van Langen","year":"2015","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.lpm.2017.04.010_bib0470","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1164\/rccm.201603-0459OC","article-title":"Sources of variation in sweat chloride measurements in cystic fibrosis","volume":"194","author":"Collaco","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.lpm.2017.04.010_bib0475","article-title":"Variability of sweat chloride concentration in subjects with cystic fibrosis and G551D mutations","author":"Vermeulen","year":"20171636","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.lpm.2017.04.010_bib0480","article-title":"Biological variability of the sweat chloride in diagnostic sweat tests: a retrospective analysis","author":"Vermeulen","year":"20171630","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.lpm.2017.04.010_bib0485","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/ng.2745","article-title":"Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene","volume":"45","author":"Sosnay","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.lpm.2017.04.010_bib0490","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1183\/09031936.00057512","article-title":"CFTR biomarkers: time for promotion to surrogate end-point","volume":"41","author":"De Boeck","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.lpm.2017.04.010_bib0495","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1378\/chest.06-2975","article-title":"Reproducibility of nasal potential difference measurements in cystic fibrosis","volume":"132","author":"Yaakov","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.lpm.2017.04.010_bib0500","doi-asserted-by":"crossref","first-page":"e66955","DOI":"10.1371\/journal.pone.0066955","article-title":"Optimizing nasal potential difference analysis for CFTR modulator development: assessment of ivacaftor in CF subjects with the G551D-CFTR mutation","volume":"8","author":"Rowe","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.lpm.2017.04.010_bib0505","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jcf.2014.08.006","article-title":"Improved repeatability of nasal potential difference with a larger surface catheter","volume":"14","author":"Vermeulen","year":"2015","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.lpm.2017.04.010_bib0510","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1164\/rccm.201003-0382OC","article-title":"Clinical phenotype and genotype of children with borderline sweat test and abnormal nasal epithelial chloride transport","volume":"182","author":"Sermet-Gaudelus","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.lpm.2017.04.010_bib0515","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1136\/thx.2009.123422","article-title":"Measurement of nasal potential difference in young children with an equivocal sweat test following newborn screening for cystic fibrosis","volume":"65","author":"Sermet-Gaudelus","year":"2010","journal-title":"Thorax"},{"issue":"Suppl. 2","key":"10.1016\/j.lpm.2017.04.010_bib0520","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jcf.2004.05.033","article-title":"Intestinal current measurements to diagnose cystic fibrosis","volume":"3","author":"Hug","year":"2004","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.lpm.2017.04.010_bib0525","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1136\/thx.2009.125088","article-title":"Intestinal current measurement for diagnostic classification of patients with questionable cystic fibrosis: validation and reference data","volume":"65","author":"Derichs","year":"2010","journal-title":"Thorax"},{"key":"10.1016\/j.lpm.2017.04.010_bib0530","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/1471-2466-14-156","article-title":"Intestinal current measurement versus nasal potential difference measurements for diagnosis of cystic fibrosis: a case-control study","volume":"14","author":"Bagheri-Hanson","year":"2014","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.lpm.2017.04.010_bib0535","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S2213-2600(16)00053-9","article-title":"Newborn screening for cystic fibrosis","volume":"4","author":"Castellani","year":"2016","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.lpm.2017.04.010_bib0540","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1542\/peds.2015-3490","article-title":"Challenges in Cystic fibrosis newborn screening and recommendations for primary care physicians","volume":"136","author":"Sosnay","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.lpm.2017.04.010_bib0545","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jcf.2015.01.001","article-title":"Cystic fibrosis screen positive, inconclusive diagnosis (cfspid): a new designation and management recommendations for infants with an inconclusive diagnosis following newborn screening","volume":"14","author":"Munck","year":"2015","journal-title":"J Cyst Fibros"},{"issue":"Suppl. 6","key":"10.1016\/j.lpm.2017.04.010_bib0550","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1016\/j.jpeds.2009.09.003","article-title":"Cystic Fibrosis Foundation practice guidelines for the management of infants with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome during the first two years of life and beyond","volume":"155","author":"Borowitz","year":"2009","journal-title":"J Pediatr"},{"key":"10.1016\/j.lpm.2017.04.010_bib0555","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/MCP.0000000000000314","article-title":"Cystic fibrosis screen positive, inconclusive diagnosis","volume":"22","author":"Barben","year":"2016","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.lpm.2017.04.010_bib0560","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1542\/peds.2015-0811","article-title":"Newborn screening for cystic fibrosis in California","volume":"136","author":"Kharrazi","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.lpm.2017.04.010_bib0565","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1002\/ppul.21475","article-title":"Clinical outcomes in infants with cystic fibrosis transmembrane conductance regulator (CFTR) related metabolic syndrome","volume":"46","author":"Ren","year":"2011","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.lpm.2017.04.010_bib0570","doi-asserted-by":"crossref","first-page":"e1386","DOI":"10.1542\/peds.2014-3698","article-title":"Outcomes of infants with indeterminate diagnosis detected by cystic fibrosis newborn screening","volume":"135","author":"Ren","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.lpm.2017.04.010_bib0575","doi-asserted-by":"crossref","first-page":"e1377","DOI":"10.1542\/peds.2014-2081","article-title":"Inconclusive diagnosis of cystic fibrosis after newborn screening","volume":"135","author":"Ooi","year":"2015","journal-title":"Pediatrics"},{"issue":"Suppl. 3","key":"10.1016\/j.lpm.2017.04.010_bib0580","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/j.jpeds.2005.08.002","article-title":"Steering Committee of the UK Cystic Fibrosis Database. Neonatal screening for cystic fibrosis is beneficial even in the context of modern treatment","volume":"147","author":"Sims","year":"2005","journal-title":"J Pediatr"},{"key":"10.1016\/j.lpm.2017.04.010_bib0585","article-title":"Differences in outcomes between early and late diagnosis of cystic fibrosis in the newborn screening era","author":"Coffey","year":"2017181137","journal-title":"J Pediatr"},{"key":"10.1016\/j.lpm.2017.04.010_bib0590","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/gim.2015.68","article-title":"Cystic fibrosis carrier screening effects on birth prevalence and newborn screening","volume":"18","author":"Castellani","year":"2016","journal-title":"Genet Med"},{"key":"10.1016\/j.lpm.2017.04.010_bib0595","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1750-1172-7-14","article-title":"Evidence for decline in the incidence of cystic fibrosis: a 35-year observational study in Brittany, France","volume":"7","author":"Scotet","year":"2012","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.lpm.2017.04.010_bib0600","doi-asserted-by":"crossref","first-page":"e1523","DOI":"10.1542\/peds.2005-3161","article-title":"Immunoreactive trypsin\/DNA newborn screening for cystic fibrosis: should the R117H variant be included in CFTR mutation panels?","volume":"118","author":"Scotet","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.lpm.2017.04.010_bib0605","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/362160a0","article-title":"Mutations in CFTR associated with mild-disease-form Cl-channels with altered pore properties","volume":"362","author":"Sheppard","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.lpm.2017.04.010_bib0610","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1086\/381001","article-title":"Variation in a repeat sequence determines whether a common variant of the cystic fibrosis transmembrane conductance regulator gene is pathogenic or benign","volume":"74","author":"Groman","year":"2004","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.lpm.2017.04.010_bib0615","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jcf.2005.09.009","article-title":"Delayed diagnosis of cystic fibrosis associated with R117H on a background of 7T polythymidine tract at intron 8","volume":"5","author":"Peckham","year":"2006","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.lpm.2017.04.010_bib0620","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1136\/jmg.2009.067215","article-title":"The very low penetrance of cystic fibrosis for the R117H mutation: a reappraisal for genetic counselling and newborn screening","volume":"46","author":"Thauvin-Robinet","year":"2009","journal-title":"J Med Genet"},{"key":"10.1016\/j.lpm.2017.04.010_bib0625","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jcf.2015.12.017","article-title":"Implementation of newborn screening for cystic fibrosis in Norway. Results from the first three years","volume":"15","author":"Lundman","year":"2016","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.lpm.2017.04.010_bib0630","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1002\/ppul.23313","article-title":"Treatment burden in patients with at least one class IV or V CFTR mutation","volume":"50","author":"Dewulf","year":"2015","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.lpm.2017.04.010_bib0635","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1378\/chest.12-1226","article-title":"Differences in the pattern of structural abnormalities on CT scan in patients with cystic fibrosis and pancreatic sufficiency or insufficiency","volume":"144","author":"Simanovsky","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.lpm.2017.04.010_bib0640","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/ppul.20054","article-title":"Relation of sweat chloride concentration to severity of lung disease in cystic fibrosis","volume":"38","author":"Davis","year":"2004","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.lpm.2017.04.010_bib0645","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3389\/fmolb.2016.00007","article-title":"Copy number variations in the survival motor neuron genes: implications for spinal muscular atrophy and other neurodegenerative diseases","volume":"3","author":"Butchbach","year":"2016","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.lpm.2017.04.010_bib0650","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/MCP.0000000000000225","article-title":"Asthma phenotypes and endotypes: a personalized approach to treatment","volume":"22","author":"Skloot","year":"2016","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.lpm.2017.04.010_bib0655","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1164\/rccm.201205-0922OC","article-title":"\u03b2-adrenergic sweat secretion as a diagnostic test for cystic fibrosis","volume":"186","author":"Quinton","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.lpm.2017.04.010_bib0660","doi-asserted-by":"crossref","first-page":"e77114","DOI":"10.1371\/journal.pone.0077114","article-title":"In vivo readout of CFTR function: ratiometric measurement of CFTR-dependent secretion by individual, identifiable human sweat glands","volume":"8","author":"Wine","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.lpm.2017.04.010_bib0665","doi-asserted-by":"crossref","first-page":"e0165254","DOI":"10.1371\/journal.pone.0165254","article-title":"Evaporimeter and bubble-imaging measures of sweat gland secretion rates","volume":"11","author":"Kim","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.lpm.2017.04.010_bib0670","doi-asserted-by":"crossref","first-page":"344ra84","DOI":"10.1126\/scitranslmed.aad8278","article-title":"Characterizing responses to CFTR-modulating drugs using rectal organoids derived from subjects with cystic fibrosis","volume":"8","author":"Dekkers","year":"2016","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.lpm.2017.04.010_bib0675","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jcf.2014.05.007","article-title":"CFTR functional measurements in human models for diagnosis, prognosis and personalized therapy: report on the pre-conference meeting to the 11th ECFS Basic Science Conference, Malta, 26\u201329 March 2014","volume":"13","author":"Beekman","year":"2014","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.lpm.2017.04.010_bib0680","doi-asserted-by":"crossref","first-page":"d1008","DOI":"10.1136\/bmj.d1008","article-title":"Improved survival at low lung function in cystic fibrosis: cohort study from 1990 to 2007","volume":"342","author":"George","year":"2011","journal-title":"BMJ"},{"issue":"Suppl. 1","key":"10.1016\/j.lpm.2017.04.010_bib0685","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.prrv.2013.01.007","article-title":"Ageing in cystic fibrosis and long-term survival","volume":"14","author":"Simmonds","year":"2013","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.lpm.2017.04.010_bib0690","article-title":"Cystic fibrosis\u00a0\u2013\u00a0comparison between patients in paediatric and adult age","author":"Santos","year":"201723200617","journal-title":"Rev Port Pneumol"},{"key":"10.1016\/j.lpm.2017.04.010_bib0695","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1164\/rccm.201001-0092OC","article-title":"Effects of gender and age at diagnosis on disease progression in long-term survivors of cystic fibrosis","volume":"182","author":"Nick","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.lpm.2017.04.010_bib0700","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ccm.2015.11.006","article-title":"Diagnosis of adult patients with cystic fibrosis","volume":"37","author":"Nick","year":"2016","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.lpm.2017.04.010_bib0705","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jcf.2014.12.005","article-title":"Breaking bad news, the diagnosis of cystic fibrosis in childhood","volume":"14","author":"Havermans","year":"2015","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.lpm.2017.04.010_bib0710","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1183\/09031936.00099506","article-title":"Cystic fibrosis mortality and survival in the UK: 1947\u20132003","volume":"29","author":"Dodge","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1016\/j.lpm.2017.04.010_bib0715","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S2213-2600(16)00023-0","article-title":"Progress in therapies for cystic fibrosis","volume":"4","author":"De Boeck","year":"2016","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.lpm.2017.04.010_bib0720","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/08964280209596397","article-title":"Communicating a diagnosis of cystic fibrosis to an adult: what physicians need to know","volume":"28","author":"Widerman","year":"2002","journal-title":"Behav Med"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075549821730221X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075549821730221X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T08:25:28Z","timestamp":1535790328000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075549821730221X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":72,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S075549821730221X"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2017.04.010","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The diagnosis of cystic fibrosis","name":"articletitle","label":"Article Title"},{"value":"La Presse M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2017.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}